Revvity Inc

US

RVTY

Health Care

100.77 ₽

Current price

Strong sell
100.77 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    194 / 240

  • Position in country

    12412 / 14179

  • Return on Assets, %

    1.2

    -2.7

  • Net income margin, %

    9.1

    -6.7

  • EBITDA margin, %

    29.8

    5.6

  • Debt to Equity, %

    49.5

    15.1

  • Intangible assets and goodwill, %

    70.4

    4.7

  • Revenue CAGR 3Y, %

    -10.1

    12.8

  • Total Equity change 1Y, %

    6.6

    -2.4

  • Revenue Y, % chg

    -17

    0

  • P/E

    71.8

    32.1

  • P/BV

    1.6

    2

  • P/S

    4.6

    4.1

  • EV/S

    5.4

    3.6

  • EV/EBITDA

    18

    7.8

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    19.7

    48.9

  • Forward P/E

    21.5

    25.5

  • Dividend Yield, %

    0.2

    0.8

  • Forward Dividend Yield, %

    0.2

    0.2

  • Expected dividend per share

    0.2

    0

  • Payout Ratio, %

    19.4

    10.1

  • Dividend Ex Date

    2024-04-18

Get an analytical review of this company

Competitors

Ranks

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Agilent Technologies Inc

    00%

  • Avantor Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Waters Corp

    00%

  • Mettler-Toledo International Inc

    00%

  • Revvity Inc

    00%

  • Illumina Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    12783.5

  • Ticker

    RVTY.K

  • ISIN

    US7140461093

  • IPO date

    1965-07-06

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-27

  • Date fact. publication of reports

    2023-12-31

Company Description

PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and Haoyuan.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: